Page last updated: 2024-11-02

perhexiline and Fibrodysplasia Ossificans Progressiva

perhexiline has been researched along with Fibrodysplasia Ossificans Progressiva in 2 studies

Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kitoh, H2
Achiwa, M1
Kaneko, H1
Mishima, K1
Matsushita, M2
Kadono, I1
Horowitz, JD1
Sallustio, BC1
Ohno, K2
Ishiguro, N2
Yamamoto, R1
Masuda, A1
Ito, M1
Katagiri, T1
Kawai, T1

Other Studies

2 other studies available for perhexiline and Fibrodysplasia Ossificans Progressiva

ArticleYear
Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial.
    Orphanet journal of rare diseases, 2013, Oct-16, Volume: 8

    Topics: Adolescent; Adult; Alkaline Phosphatase; Female; Humans; Male; Myositis Ossificans; Osteocalcin; Per

2013
Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.
    Journal of bone and mineral metabolism, 2013, Volume: 31, Issue:1

    Topics: Activin Receptors, Type I; Animals; Bone Morphogenetic Protein 2; Calcium Channel Blockers; Cell Lin

2013